venBio Global Strategic Fund L.P. 13D and 13G filings for Metacrine, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 2:33 pm Sale | 2021-12-31 | 13G | Metacrine, Inc. MTCR | venBio Global Strategic Fund L.P. | 0 0.000% | -3,059,123 (Position Closed) | Filing |
| 2021-02-16 4:53 pm Purchase | 2020-12-31 | 13G | Metacrine, Inc. MTCR | venBio Global Strategic Fund L.P. | 3,059,123 11.800% | 3,059,123 (New Position) | Filing |